Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2245-2251

  Zeng, Qing ^a   Smith, David C ^d   Suscovich, Todd J ^a   Gooding, William E ^b   Trump, Donald L ^a   Grandis, Jennifer Rubin ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c University of Pittsburgh School of Medicine   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; CYTOCHROME P450 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIAROZOLE; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR; RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BIOPSY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MOUTH MUCOSA; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ACTINS; ANTINEOPLASTIC AGENTS, HORMONAL; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMIDAZOLES; MOUTH MUCOSA; MOUTH NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA; TRETINOIN; UP-REGULATION;

EID: 0034042952     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sporn, M. B., and Roberts, A. B. Role of retinoids in differentiation and carcinogenesis. J. Natl. Cancer Inst., 76: 1381-1387, 1984.
2. Martin, C. A., Ziegler, L. M., and Napoli, J. L. Retinoid acid, dibutyrl-cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells. Proc. Natl. Acad. Sci. USA, 87: 4804-4808, 1990.
3. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science (Washington DC), 240: 889-895, 1988.
4. Leid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., and Chen, J. Y. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell, 68: 377-395, 1992.
5. Lotan, R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst., 87: 1655-1657, 1995.
6. Vettermann, O., Siegenthaler, G., Winter, H., and Schweizer, J. Retinoic acid signaling cascade in differentiating murine epidermal keratinocytes: alterations in papilloma-and carcinoma-derived cell lines. Mol. Carcinog., 20: 58-67, 1997.
7. Bichler, E., Daxenbichler, G., and Marth, C. Vitamin A status and retinoid-binding proteins in carcinomas of the head and neck region. Oncology (Basel), 40: 336-339, 1983.
8. Ibrahim, K., Jafrey, N. A., and Zuberi, S. J. Plasma vitamin "A" and carotene levels in squamous cell carcinoma of oral cavity and oropharynx. Clin. Oncol., 3: 203-207, 1977.
9. Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., and Hong, W. K. Comparison of low-dose isotretinoin with β-carotene to prevent oral carcinogenesis. N. Engl. J. Med., 328: 15-20, 1993.
10. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., et al. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
11. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotran, R., Peters, L. J., et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
12. Benner, S. E., Lippman, S. M., and Hong, W. K. Retinoid chemoprevention of second primary tumors. Semin. Hematol., 31 (Suppl. 5): 26-30, 1994.
13. Rubin Grandis, J., and Tweardy, D. J. TGF-α and EGFR in head and neck cancer. J. Cell. Biochem., 17F (Suppl.): 188-191, 1993.
14. Rubin Grandis, J., Melhem, M. F., Barnes, E. L., and Tweardy, D. J. Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer (Phila.), 78: 1284-1292, 1996.
15. Rubin Grandis, J., Zeng, Q., and Tweardy, D. J. Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGFR in head and neck cancer cell lines. Nat. Med., 2: 237-240, 1996.
16. Rubin Grandis, J., Tweardy, D. J., and Melhem, M. F. Asynchronous modulation of transforming growth factor a and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin. Cancer Res., 4: 13-20, 1998.
17. Silverman, A. K., Ellis, C. N., and Voorhees, J. J. Hypervitaminosis A syndrome: a paradigm of retinoid side effects. J. Am. Acad. Dermatol., 16: 1027-1039, 1987.
18. Van Wauwe, J. P., Van Nyen, G., Coene, M. C., Stoppie, P., Cools, W., Goossens, J., Borghgraef, P., and Janssen, P. A. Liarazole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J. Pharmaol. Exp. Ther., 261: 773-779, 1992.
19. Wong, H., Anderson, W. D., Cheng, T., and Riabowol, K. T. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal. Biochem., 223: 251-258, 1994.
20. Warrell, R. P., Jr. Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood, 82: 1949-1953, 1993.
21. Smets, G., Van Ginckel, R., Daneels, G., Moeremans, M., Van Wauwe, J., Coene, M. C., Ramaekers, F. C., Schalken, J. A., Borgers, M., and DeCoster, R. Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid. Prostate, 27: 129-140, 1995.
22. Gudas, L. J. Retinoids and vertebrate development. J. Biol. Chem., 269: 15399-15402, 1994.
23. Gilliland, G., Perrin, S., Blanchard, K., and Bunn, H. F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 2725-2729, 1990.
24. Diviacco, S., Norio, P., Zentilin, L., Menzo, S., Clementi, M., Biamonti, G., Riva, S., Falaschi, A., and Giacca, M. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene (Amst.), 122: 313-320, 1992.
25. Platzer, C., Richter, G., Uberla, K., Muller, W., Blocker, H., Diamanstein, T., and Blankenstein, T. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol., 22: 1179-1184, 1992.